CTSO news

Latest 1 stories · newest Sep 23, 2026

CTSO

CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement

The company regained compliance with the Nasdaq minimum bid price requirement and plans to address remaining listing standards by December 2026 while advancing clinical programs.

Regulatory Sep 23, 2026 sentiment +0.65 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CTSO feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CTSO/newsSTART FREE